Eli Lilly and Company Announces Executive Changes

Eli Lilly and Company has announced that Patrik Jonsson and Ilya Yuffa will be transitioning roles as of October 1, 2020, both reporting to Chairman/Chief Executive Officer, David Ricks. Patrik will become Senior Vice President, President of Lilly USA and Chief Customer Officer. Meanwhile, Ilya will be promoted from his position as Vice President of US Diabetes in order to take on Patrik’s former role as Senior Vice President and President of Lilly Bio-Medicines. Patrik and Ilya will both be executive committee members as well.

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. In 2019, Eli Lilly’s reported revenue was $24.56 billion while employing roughly 33,000 employees globally.